The UK government has confirmed that it will continue to accept CE marked medical devices on a long-term basis, meaning ...
Delegates at this year’s Vascular Access Society of Britain and Ireland (VASBI) annual scientific meeting (24–25 September, ...
Haemonetics has announced US Food and Drug Administration (FDA) approval of the PerQseal Elite vascular closure system for large-bore arterial procedures. According to the company, the approval ...
Gore today announced US Food and Drug Administration (FDA) approval of an expanded indication for the company’s Viabahn VBX balloon-expandable endoprosthesis (VBX stent graft) for use in fenestrated ...
A subset analysis of the landmark STORM-PE randomised controlled trial (RCT) demonstrated a significant correlation between real-world, daily step-based activity as captured on a consumer wearable ...
Stefano Barco (University Hospital Zurich, Zurich, Switzerland) talks through the superior one-year outcome data from the SirPAD randomised controlled trial (RCT) comparing the MagicTouch PTA ...
“The future of vascular surgery is incredibly bright,” Daniel Clair (Vanderbilt University Medical Center [VUMC], Nashville, USA) opines in this interview with Vascular News on his career in the field ...
Crossing chronic total occlusion (CTO) lesions are challenging procedures. The BeBack crossing catheter—Bentley’s first product to be available in both Europe and the USA following the company’s ...
Nectero Medical recently announced that the American Medical Association’s CPT editorial panel has approved two category III CPT codes applicable to the Nectero endovascular aneurysm stabilisation ...
Embolization recently announced it has recevied 510(k) clearance from the US Food and Drug Administration (FDA) for its Nitinol Enhanced Device (NED)—a vascular embolisation device intended for ...
Endologix has announced the appointment of Matthew Thompson as president and chief executive officer. Thompson will also join Endologix’s board of directors. Richard Mott, who previously held the CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results